Clinical Trials in Salt Lake City

Showing 2581-2600 of 16,694 trials

Study of Serine Supplementation to Protect Vision in MacTel

NCT07342439

The goal of this clinical trial is to look at the efficacy and safety of giving oral serine (an amino acid) on the progression of structural and functional changes of the retina in people with MacTel type 2. The main questions it aims to answer are: * Does serine slow the progression of MacTel? * Is long-term serine supplementation safe in people with MacTel? Researchers will compare serine to a placebo (a look-alike substance that contains no drug) to see if serine works to slow the progression of MacTel. Participants will: * Take serine or a placebo twice a day for 24 months * Visit the clinic once every 6 months for eye exam, eye imaging and blood tests * Keep a diary of their symptoms, missed doses, and changes in medications

Macular Telangiectasia Type 2 (MacTel)

The Lowy Medical Research Institute Limited120 participantsStarted Sep 2026

La Jolla, California, United States • Ann Arbor, Michigan, United States • Cleveland, Ohio, United States +9 more locations

Active Not RecruitingPhase 37.5 miles

A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

NCT06104124

Primary Objective: To evaluate the effect of dazodalibep on systemic manifestations of Sjögren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity. Secondary Objectives: 1. To evaluate the effect of dazodalibep on patient reported outcomes (PROs) in participants with SS. 2. To evaluate the safety and tolerability of dazodalibep in participants with SS

Sjogren's Syndrome

Amgen651 participantsStarted Jan 2024

Avondale, Arizona, United States • Chandler, Arizona, United States • Flagstaff, Arizona, United States +213 more locations

Study of Serine Supplementation to Protect Vision in MacTel

A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Find Trials by Condition in Salt Lake City

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

Perf-Fix Study for Chronic Tympanic Membrane Repair

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder

Prostate Active Surveillance Study

@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears